Cargando…

Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review

Cosmetic or therapeutic use of botulinum toxin type A (BoNT-A) is usually safe but can rarely cause iatrogenic botulism. Iatrogenic botulism and myasthenia gravis (MG) share similar clinical features, because both BoNT-A and anti-acetylcholine receptorantibodies impair neuromuscular transmission. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmermans, Grégory, Depierreux, Frédérique, Wang, François, Hansen, Isabelle, Maquet, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751432/ https://www.ncbi.nlm.nih.gov/pubmed/31572161 http://dx.doi.org/10.1159/000502350

Ejemplares similares

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Bhaskar, Shalini, et al.
Publicado: (2022)

Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

A diagnosis of late-onset Myasthenia gravis unmasked by topical antibiotics
por: Hussain, Nooreen, et al.
Publicado: (2018)

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use
por: Namazi, Nastaran, et al.
Publicado: (2016)

Case Report of Subclinical Myasthenia Gravis Associated with Castleman Disease
por: Alsinan, Tuqa Adil, et al.
Publicado: (2021)

Unilateral transient mydriasis and ptosis after botulinum toxin injection for a cosmetic procedure
por: Akkaya, Sezen, et al.
Publicado: (2015)

Cosmetic use of botulinum toxin type A in the elderly
por: Cheng, Christine M
Publicado: (2007)

Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)
por: Bai, Lili, et al.
Publicado: (2018)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Botulinum toxin – From WMD to therapeutic agent and cosmetic aid
por: Pinder, Roger M
Publicado: (2007)

Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action
por: Wollina, Uwe
Publicado: (2008)

Incidental Treatment of a Subclinical Chronic Tension-Type Headache by Cosmetic Use of Botulinum Toxin A: A Case Report
por: Saltvig, Iselin, et al.
Publicado: (2017)

Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis
por: Zargaran, David, et al.
Publicado: (2022)

Subcutaneous infection caused by Mycobacterium abscessus following cosmetic injections of botulinum toxin: A case report
por: Deng, Lin, et al.
Publicado: (2022)

Maximizing botulinum toxin injections for cosmetic and therapeutic applications with a single use, disposable, exact dose injection assist device
por: Kwolek, Marilyn S, et al.
Publicado: (2019)

Unmasking of Myasthenia Gravis After Introduction of Oral Risperidone in a Schizophrenic Saudi Male: A Case Report
por: Abualkhair, Lamees, et al.
Publicado: (2021)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Regulatory B cells in myasthenia gravis are differentially affected by therapies
por: Yilmaz, Vuslat, et al.
Publicado: (2018)

An Update on the Cosmetic Use of Botulinum Toxin: The Pattern of Practice among Korean Dermatologists
por: Rho, Nark-Kyoung, et al.
Publicado: (2022)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Pathomechanisms of Paraneoplastic Myasthenia Gravis
por: Ströbel, Philipp, et al.
Publicado: (2003)

The Intrathymic Pathogenesis of Myasthenia Gravis
por: Levinson, Arnold I., et al.
Publicado: (2004)

Castleman's Disease with Myasthenia Gravis
por: Lee, Sang-Kwon, et al.
Publicado: (2012)

Insights into the Classification of Myasthenia Gravis
por: Akaishi, Tetsuya, et al.
Publicado: (2014)

Myasthenia Gravis: A Review
por: Jayam Trouth, Annapurni, et al.
Publicado: (2012)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l07822tiu7j02533se85r5hcc7